CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
3.49
0%
Market Trading Hours* (UTC) Open now
Closes on Thursday at 20:00

Mon - Thu: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Codexis Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 3.49
Open* 3.51
1-Year Change* -7.63%
Day's Range* 3.49 - 3.69
52 wk Range 1.45-6.98
Average Volume (10 days) 482.70K
Average Volume (3 months) 16.25M
Market Cap 187.15M
P/E Ratio -100.00K
Shares Outstanding 69.83M
Revenue 73.96M
EPS -1.21
Dividend (Yield %) N/A
Beta 1.90
Next Earnings Date Feb 21, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 27, 2024 3.49 0.10 2.95% 3.39 3.57 3.39
Mar 26, 2024 3.43 0.00 0.00% 3.43 3.56 3.43
Mar 25, 2024 3.43 0.04 1.18% 3.39 3.52 3.38
Mar 22, 2024 3.43 0.06 1.78% 3.37 3.54 3.36
Mar 21, 2024 3.47 -0.02 -0.57% 3.49 3.65 3.46
Mar 20, 2024 3.47 0.23 7.10% 3.24 3.58 3.15
Mar 19, 2024 3.25 0.16 5.18% 3.09 3.34 3.09
Mar 18, 2024 3.23 -0.07 -2.12% 3.30 3.30 3.01
Mar 15, 2024 3.29 0.15 4.78% 3.14 3.32 3.14
Mar 14, 2024 3.18 -0.16 -4.79% 3.34 3.39 3.15
Mar 13, 2024 3.36 -0.04 -1.18% 3.40 3.62 3.32
Mar 12, 2024 3.44 -0.10 -2.82% 3.54 3.63 3.40
Mar 11, 2024 3.59 0.15 4.36% 3.44 3.82 3.44
Mar 8, 2024 3.45 -0.22 -5.99% 3.67 3.81 3.37
Mar 7, 2024 3.64 -0.01 -0.27% 3.65 3.80 3.58
Mar 6, 2024 3.61 -0.23 -5.99% 3.84 3.84 3.52
Mar 5, 2024 3.74 -0.39 -9.44% 4.13 4.23 3.69
Mar 4, 2024 4.18 -0.47 -10.11% 4.65 4.65 4.18
Mar 1, 2024 4.59 -0.05 -1.08% 4.64 4.65 4.14
Feb 29, 2024 4.66 0.79 20.41% 3.87 4.87 3.87

Codexis Events

Time (UTC) Country Event
Thursday, May 2, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 Codexis Inc Earnings Release
Q1 2024 Codexis Inc Earnings Release

Forecast

-

Previous

-
Wednesday, June 12, 2024

Time (UTC)

16:00

Country

US

Event

Codexis Inc Annual Shareholders Meeting
Codexis Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 138.59 104.754 69.056 68.458 60.594
Revenue 138.59 104.754 69.056 68.458 60.594
Cost of Revenue, Total 38.033 22.209 13.742 15.632 12.62
Gross Profit 100.557 82.545 55.314 52.826 47.974
Total Operating Expense 173.471 127.451 92.976 81.007 71.889
Selling/General/Admin. Expenses, Total 52.172 49.323 35.049 31.502 29.291
Research & Development 80.099 55.919 44.185 33.873 29.978
Operating Income -34.881 -22.697 -23.92 -12.549 -11.295
Interest Income (Expense), Net Non-Operating 1.441 0.459 0.405 1.287 0.671
Other, Net 0.124 1.148 -0.156 -0.656 -0.291
Net Income Before Taxes -33.316 -21.09 -23.671 -11.918 -10.915
Net Income After Taxes -33.592 -21.279 -24.01 -11.935 -10.878
Net Income Before Extra. Items -33.592 -21.279 -24.01 -11.935 -10.878
Net Income -33.592 -21.279 -24.01 -11.935 -10.878
Income Available to Common Excl. Extra. Items -33.592 -21.279 -24.01 -11.935 -10.878
Income Available to Common Incl. Extra. Items -33.592 -21.279 -24.01 -11.935 -10.878
Diluted Net Income -33.592 -21.279 -24.01 -11.935 -10.878
Diluted Weighted Average Shares 65.344 64.568 59.36 56.525 52.205
Diluted EPS Excluding Extraordinary Items -0.51408 -0.32956 -0.40448 -0.21115 -0.20837
Diluted Normalized EPS -0.48258 -0.32956 -0.40448 -0.21115 -0.20837
Total Extraordinary Items
Unusual Expense (Income) 3.167
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 21.323 12.982 30.375 34.47 38.406
Revenue 21.323 12.982 30.375 34.47 38.406
Cost of Revenue, Total 3.178 4.521 8.456 9.786 11.27
Gross Profit 18.145 8.461 21.919 24.684 27.136
Total Operating Expense 33.949 36.647 43.625 45.106 41.015
Selling/General/Admin. Expenses, Total 13.365 15.399 12.313 13.499 10.656
Research & Development 17.334 16.655 19.689 21.821 19.089
Operating Income -12.626 -23.665 -13.25 -10.636 -2.609
Interest Income (Expense), Net Non-Operating 1.121 1.089 0.823 0.436 0.14
Other, Net -0.009 -0.025 -0.026 0.216 -0.063
Net Income Before Taxes -11.514 -22.601 -12.453 -9.984 -2.532
Net Income After Taxes -11.523 -22.617 -12.604 -9.992 -2.64
Net Income Before Extra. Items -11.523 -22.617 -12.604 -9.992 -2.64
Net Income -11.523 -22.617 -12.604 -9.992 -2.64
Income Available to Common Excl. Extra. Items -11.523 -22.617 -12.604 -9.992 -2.64
Income Available to Common Incl. Extra. Items -11.523 -22.617 -12.604 -9.992 -2.64
Diluted Net Income -11.523 -22.617 -12.604 -9.992 -2.64
Diluted Weighted Average Shares 67.573 65.931 65.563 65.426 65.288
Diluted EPS Excluding Extraordinary Items -0.17053 -0.34304 -0.19224 -0.15272 -0.04044
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.16983 -0.34233 -0.16084 -0.15272 -0.04044
Unusual Expense (Income) 0.072 0.072 3.167
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 162.894 161.888 184.423 114.205 68.198
Cash and Short Term Investments 113.984 116.797 150.117 90.498 53.039
Cash & Equivalents 113.984 116.797 149.117 90.498 53.039
Total Receivables, Net 40.873 37.652 29.288 20.155 13.502
Accounts Receivable - Trade, Net 40.873 37.652 29.288 20.155 13.502
Total Inventory 2.029 1.16 0.964 0.371 0.589
Prepaid Expenses 5.487 5.7 3.416 2.52 1.068
Total Assets 250.393 246.383 221.646 149.073 79.283
Property/Plant/Equipment, Total - Net 61.877 65.457 31.176 30.387 4.759
Property/Plant/Equipment, Total - Gross 101.698 101.339 64.549 63.638 37.852
Accumulated Depreciation, Total -39.821 -35.882 -33.373 -33.251 -33.093
Goodwill, Net 3.241 3.241 3.241 3.241 3.241
Intangibles, Net
Long Term Investments 20.51 14.002 1.45 0 0.588
Other Long Term Assets, Total 1.871 1.795 1.356 1.24 2.497
Total Current Liabilities 49.066 33.371 24.981 15.388 18.113
Accounts Payable 3.246 2.995 2.97 2.621 3.05
Accrued Expenses 32.092 27.79 20.187 12.65 9.359
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 13.728 2.586 1.824 0.057 5.704
Total Liabilities 105.596 81.992 51.543 43.556 22.977
Total Long Term Debt 0 0 0 0 0.061
Other Liabilities, Total 56.53 48.621 26.562 28.168 4.803
Total Equity 144.797 164.391 170.103 105.517 56.306
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.006 0.006 0.006 0.006 0.005
Additional Paid-In Capital 566.081 552.083 536.516 447.92 386.775
Retained Earnings (Accumulated Deficit) -421.29 -387.698 -366.419 -342.409 -330.474
Other Equity, Total 0
Total Liabilities & Shareholders’ Equity 250.393 246.383 221.646 149.073 79.283
Total Common Shares Outstanding 65.811 65.109 64.283 58.877 54.065
Capital Lease Obligations 0 0.061
Other Current Assets, Total 0.521 0.579 0.638 0.661
Current Port. of LT Debt/Capital Leases 0 0.06
Short Term Investments 0 1
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 103.014 120.044 129.954 162.894 145.997
Cash and Short Term Investments 74.577 92.093 102.831 113.984 108.689
Cash & Equivalents 74.577 92.093 102.831 113.984 108.689
Short Term Investments
Total Receivables, Net 19.093 21.612 20.017 40.873 29.775
Accounts Receivable - Trade, Net 19.093 21.612 20.017 40.873 29.775
Total Inventory 2.305 2.052 1.996 2.029 1.623
Prepaid Expenses 5.402 3.763 4.585 5.487 5.382
Other Current Assets, Total 1.637 0.524 0.525 0.521 0.528
Total Assets 154.455 206.761 218.068 250.393 235.288
Property/Plant/Equipment, Total - Net 29.177 60.07 61.622 61.877 63.812
Property/Plant/Equipment, Total - Gross 68.264 102.542 102.784 101.698 103.162
Accumulated Depreciation, Total -39.087 -42.472 -41.162 -39.821 -39.35
Goodwill, Net 2.463 3.241 3.241 3.241 3.241
Long Term Investments 18.013 21.378 21.31 20.51 20.51
Other Long Term Assets, Total 1.788 2.028 1.941 1.871 1.728
Total Current Liabilities 38.415 35.736 38.311 49.066 31.908
Accounts Payable 3.098 4.042 4.494 3.246 2.621
Accrued Expenses 26.081 21.165 20.443 32.092 27.685
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 9.236 10.529 13.374 13.728 1.602
Total Liabilities 62.949 82.63 92.052 105.596 81.157
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 24.534 46.894 53.741 56.53 49.249
Total Equity 91.506 124.131 126.016 144.797 154.131
Redeemable Preferred Stock 0 0 0
Common Stock 0.006 0.006 0.006 0.006 0.006
Additional Paid-In Capital 581.838 579.555 569.917 566.081 562.811
Retained Earnings (Accumulated Deficit) -490.338 -455.43 -443.907 -421.29 -408.686
Total Liabilities & Shareholders’ Equity 154.455 206.761 218.068 250.393 235.288
Total Common Shares Outstanding 69.827 69.804 66.696 65.811 65.613
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -33.592 -21.279 -24.01 -11.935 -10.878
Cash From Operating Activities 11.284 -14.267 -16.464 -12.56 -14.094
Cash From Operating Activities 5.42 3.219 2.102 1.787 1.147
Amortization 0
Non-Cash Items 17.884 11.417 9.335 10.238 7.98
Cash Taxes Paid 0.1 0.102 0.312 0.005 0.005
Cash Interest Paid 0.034 0.014 0.052 0.049 0.084
Changes in Working Capital 21.572 -7.624 -3.891 -12.65 -12.343
Cash From Investing Activities -13.578 -21.422 -5.748 -3.665 -2.766
Capital Expenditures -8.307 -13.828 -3.748 -3.73 -2.768
Other Investing Cash Flow Items, Total -5.271 -7.594 -2 0.065 0.002
Cash From Financing Activities -0.575 3.767 80.808 53.961 38.569
Financing Cash Flow Items -1.53 -1.413 -6.705 -2.896 -3.37
Issuance (Retirement) of Stock, Net 0.955 5.18 87.573 57.099 42.177
Issuance (Retirement) of Debt, Net 0 0 -0.06 -0.242 -0.238
Net Change in Cash -2.869 -31.922 58.596 37.736 21.709
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -22.617 -33.592 -20.988 -10.996 -8.356
Cash From Operating Activities -9.212 11.284 6.367 -13.367 -11.186
Cash From Operating Activities 1.466 5.42 3.961 2.556 1.215
Non-Cash Items 4.003 17.884 13.429 8.896 4.786
Cash Interest Paid 0.007 0.034 0.022 0.012 0.005
Changes in Working Capital 7.936 21.572 9.965 -13.823 -8.831
Cash From Investing Activities -3.284 -13.578 -13.611 -12.302 -10.082
Capital Expenditures -2.539 -8.307 -8.34 -7.03 -5.089
Other Investing Cash Flow Items, Total -0.745 -5.271 -5.271 -5.272 -4.993
Cash From Financing Activities 1.352 -0.575 -0.914 -1.047 -1.28
Financing Cash Flow Items -0.469 -1.53 -1.526 -1.479 -1.461
Issuance (Retirement) of Stock, Net 1.821 0.955 0.612 0.432 0.181
Issuance (Retirement) of Debt, Net 0
Net Change in Cash -11.144 -2.869 -8.158 -26.716 -22.548
Cash Taxes Paid 0.193 0.1 0.1

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Codexis Company profile

About Codexis, Inc.

Codexis, Inc. is a enzyme engineering company. The Company is engaged in discovering, developing and sells enzymes and other proteins. The Company operates through two segments: Performance Enzymes and Novel Biotherapeutics. The Company’s CodeEvolver technology platform accelerates biologic discovery through the transformation of a starting enzyme into a biocatalyst or therapeutic candidate. The Company has commercialized its CodeEvolver protein engineering technology platform and products in the pharmaceutical’s markets. The Company’s products include Codex HiFi Hot Start DNA Polymerase and Codex HiCap RNA Polymerase. The Company serves various industries, including food and food ingredients, animal feed, flavors, fragrances, and agricultural chemical.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Codexis, Inc. revenues increased 52% to $104.8M. Net loss decreased 11% to $21.3M. Revenues reflect Performance Enzymes segment increase of 88% to $90.5M, APAC segment increase from $25.4M to $61.1M, EMEA segment increase of 5% to $20.2M. Lower net loss reflects Performance Enzymes segment income increase from $3.8M to $33.1M.

Equity composition

Common Stock $0.0001 Par, 04/11, 100M auth., 35,573,003 issd. Insiders own approx. 16.85%. PO:TBA. 09/08, Company withdrawn its IPO.

Industry: Biotechnology & Medical Research (NEC)

200 Penobscot Dr
REDWOOD CITY
CALIFORNIA 94063
US

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

XRP/USD

0.64 Price
+3.240% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,218.08 Price
+1.050% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.30

BTC/USD

70,659.20 Price
+2.540% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

18,236.90 Price
-0.240% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading